Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
To evaluate the efficacy and safety of Huaier Granule for prevention of disease progression of hepatocarcinoma after non-radical hepatectomy.
Hepatic Carcinoma
DRUG: Huaier Granule
Time to significant progression after surgery and postoperative survival period., Time to significant progression after surgery, including recurrence of local tumor, intrahepatic and extrahepatic metastasis, etc; and to evaluation of postoperative survival period., 3 years
ECOG and QLQ-C30 scores, On week 8, 16, 24, 32, 40, 48, 60, 72, 84, 96, 108, 120, 132 and 144, assess the scores of Eastern Cooperative Oncology Group(ECOG) and quality of life questionnaire(QLQ)-C30 scale., Week 8, 16, 24, 32, 40, 48, 60, 72, 84, 96, 108, 120, 132, 144|Iconography assessment, On week 16, 24, 32, 40, 48, 60, 72, 84, 96, 108, 120, 132 and 144, give examination of B ultrasonic for Liver, X-ray for chest. If there is a suspected recurrence or metastases, will give enhancement CT/MRI examination for liver and chest; if no recurrence or metastases, will at least give enhancement CT/MRI examination for liver and chest every year., Week 16, 24, 32, 40, 48, 60, 72, 84, 96, 108, 120, 132, 144|Alpha-fetoprotein quantitation and related biochemical indicators, On week 8, 16, 24, 32, 40, 48, 60, 72, 84, 96, 108, 120, 132 and 144, monitor Alpha-fetoprotein quantitation., Week 8, 16, 24, 32, 40, 48, 60, 72, 84, 96, 108, 120, 132, 144
A Prospective, Multicenter, Open-labeled, Parallel -controlled Clinical Study, to evaluate the efficacy and safety of Huaier Granule for prevention of disease progression of hepatocarcinoma after non-radical hepatectomy.